Health + Education

Egypt’s SEDICO to complete EGP 300 mn pharmaceuticals factory by end-2019

by enterpriseam adminEgypt Edition26 December 2018

Read Full Issue

SEDICO Pharmaceutical Company is planning to complete a EGP 300 mn antineoplastics factory by the end of 2019, Chairman Awad Gabr said. Antineoplastics are medicines used to prevent tumors. Gabr did not mention the location or capacity of the planned facility, but noted that production will begin in 2020.

Related

Tags:

Health + Education healthcare pharma

More from Enterprise

Banking

Israel’s Arkia Airlines moves flights to Egypt’s Taba to bypass wartime airspace restrictions

Israel’s Arkia Airlines moves flights to Egypt’s Taba to bypass wartime airspace restrictions

Israel’s Arkia shifts some flights to Egypt as airspace tightens…

Finance

Miga guarantee unlocks USD 313 mn for National Bank of Egypt trade finance

Miga guarantee unlocks USD 313 mn for National Bank of Egypt trade finance

Plus: Incolease taps securitization market with debut EGP 2 bn…

Capital Markets

Private capital hasn’t frozen in MENA — but the exit playbook could change if the war drags on

Private capital hasn’t frozen in MENA — but the exit playbook could change if the war drags on

PE and VC-backed companies were already pivoting to local exchanges…

Fintech

Telda moves into investing with zero-fee stock trading

Telda moves into investing with zero-fee stock trading

Telda claims users can sell a position and immediately spend…

Now Playing

Now Playing

00:00

00:00